URI Researchers Proposed AI Pharmacy Accountability Framework
The study outlines how human oversight remains essential for medical decisions in managed care environments.
Updated on Sept. 21, 2026 in Artificial Intelligence
Live Poll
Do you trust AI-assisted medical decisions made without explicit human pharmacist review?
Researchers at the University of Rhode Island have published a new framework to ensure pharmacists maintain accountability when using AI in managed care workflows. The peer-reviewed research highlights the necessity of keeping human clinical judgment at the center of medical necessity determinations.
Why it matters
As AI tools become increasingly common in healthcare settings, they create potential accountability gaps regarding final decision-making responsibility. This framework provides a structured approach to bridge that gap by synthesizing existing federal regulatory guidance with professional pharmacy standards.
The study, published in Volume 32, Issue 9, pages 1130-1134 of the Journal of Managed Care & Specialty Pharmacy, formalizes documentation practices for AI-assisted workflows. It explicitly aligns these processes with oversight findings from the Office of Inspector General.
The players
University of Rhode Island
This is a public research university located in Kingston, Rhode Island, where the team developed the accountability framework.
Journal of Managed Care & Specialty Pharmacy
This peer-reviewed publication serves as the primary outlet for research concerning health plans and pharmacy benefits.
Centers for Medicare & Medicaid Services
This federal agency establishes the regulatory requirements for medical necessity determinations in managed care.
Office of Inspector General
This entity provides federal oversight and reporting on the integrity of programs under the Department of Health and Human Services.
The details
The framework utilizes a human-in-the-loop review process that demands pharmacists audit and confirm AI-generated clinical suggestions. By integrating requirements from the Centers for Medicare & Medicaid Services, the researchers ensure that automated tools support rather than replace human clinical expertise.
Timeline
The research was published in September 2026.
The Tech Race
The research framework extends the existing Centers for Medicare & Medicaid Services medical necessity determination requirements by formalizing how pharmacists apply those rules within AI-driven systems. This effort represents a significant shift toward standardizing human-led governance in an era where automated diagnostic tools threaten to displace traditional clinical review processes.
Patients may benefit from increased transparency and standardized human review processes when their pharmacy managed care decisions involve AI assistance. This development seeks to ensure that critical medication coverage determinations remain subject to professional oversight rather than black-box algorithms.
The takeaway
Maintaining human oversight in AI-driven pharmacy decisions is essential to protecting patient safety and clinical integrity. Pharmacists are encouraged to adopt these auditability standards to ensure their professional judgment remains the final authority in managed care.
Further reading
For more context on how automated tools are reshaping medical workflows, visit the Artificial Intelligence section.
Live Poll
Do you trust AI-assisted medical decisions made without explicit human pharmacist review?
